Pinned Tweet
The best signal in a partnership is when both sides want to do more.
This week, BI and Variant Bio are expanding our collaboration into CVD, combining BI's expertise with our proprietary data and AI-powered platform.
Grateful to the teams on both sides who made this happen.
Thrilled to announce our latest drug development collaboration! We are now expanding our existing partnership with @Boehringer into cardiovascular disease for a total potential deal value exceeding $250 mm: prnewswire.com/news-releases…
Andrew Farnum retweeted
Awesome story. Awesome team at Variant Bio.
One of the great joys of starting this company has been getting to work with @bborrell more. He's one of the finest science writers around, and it's such an honor to publish him.
(Best of all, we grew up together and were the writer dorks at school. How funny to end up here together all these years later.)
You will not read a better story this week. corememory.com/p/variant-bio…
Andrew Farnum retweeted
One of the great joys of starting this company has been getting to work with @bborrell more. He's one of the finest science writers around, and it's such an honor to publish him.
(Best of all, we grew up together and were the writer dorks at school. How funny to end up here together all these years later.)
You will not read a better story this week. corememory.com/p/variant-bio…
Andrew Farnum retweeted
An incredible story by @bborrell and work from @VariantBio.
It’s a reminder that science is a long game—and that technology companies can be both world-changing and community-focused.
Also, great science journalism is a public good worth supporting. Props to @ashleevance and team.
best story ever just dropped!!!!! i love getting asked to read a piece before publishing and witnessing a banger be born corememory.com/p/variant-bio…
Andrew Farnum retweeted
Snails, worms and the next blockbuster drug
Crazy story - corememory.com/p/variant-bio…
Andrew Farnum retweeted
She's not wrong
best story ever just dropped!!!!! i love getting asked to read a piece before publishing and witnessing a banger be born corememory.com/p/variant-bio…
Andrew Farnum retweeted
best story ever just dropped!!!!! i love getting asked to read a piece before publishing and witnessing a banger be born corememory.com/p/variant-bio…
Andrew Farnum retweeted
For the past few years, there's been a company called Variant Bio scouring the world to find people with very unique genes. The hope has been to turn the genetic oddities into new drugs for the masses.
Here's our story on this work - corememory.com/p/variant-bio…
Andrew Farnum retweeted
New coverage in @corememory tells the origins of @VariantBio’s first drug candidate, and the power of human genetics to discover new medicines: medium.com/variantbio/from-t…
Andrew Farnum retweeted
New piece out about @VariantBio's lead drug program in pulmonary fibrosis and Dr. Alain Dessein, our inspiring research collaborator in Uganda:
A researcher studying flatworms for decades may have discovered some gene variants key to the next blockbuster drug.
This is our story by @bborrell on how @VariantBio is finding new therapies in places everyone else has ignored. corememory.com/p/variant-bio…
Andrew Farnum retweeted
A researcher studying flatworms for decades may have discovered some gene variants key to the next blockbuster drug.
This is our story by @bborrell on how @VariantBio is finding new therapies in places everyone else has ignored. corememory.com/p/variant-bio…
Thank you @ashleevance and Core Memory for giving this story the room it deserves. Alain Dessein’s forty years of fieldwork and the generosity of the Lake Albert communities are why we have a fibrosis program heading toward the clinic.
A researcher studying flatworms for decades may have discovered some gene variants key to the next blockbuster drug.
This is our story by @bborrell on how @VariantBio is finding new therapies in places everyone else has ignored. corememory.com/p/variant-bio…
Andrew Farnum retweeted
A researcher studying flatworms for decades may have discovered some gene variants key to the next blockbuster drug.
This is our story by @bborrell on how @VariantBio is finding new therapies in places everyone else has ignored. corememory.com/p/variant-bio…
From a parasitic disease in Africa to a potential new treatment for pulmonary fibrosis. An incredible story about the origins of Variant Bio's first drug candidate, and the power of human genetics to uncover new medicines. Great reporting by @bborrell!
Alain Dessein discovered a group of Ugandan fishermen with genes protecting them from a horrifying parasitic disease. Now, these findings have led to a new drug that may help the rest of us. corememory.com/p/variant-bio…
2
95
Andrew Farnum retweeted
Alain Dessein discovered a group of Ugandan fishermen with genes protecting them from a horrifying parasitic disease. Now, these findings have led to a new drug that may help the rest of us. corememory.com/p/variant-bio…
Andrew Farnum retweeted
Findings from our recent papers in @ScienceMagazine and @NatureComms include health risks and drug-target leads the largest databases miss: medium.com/variantbio/two-pa…
Andrew Farnum retweeted
With co-author @stephanecastel of @VariantBio in front of our cover of @ScienceMagazine at ASHG @GeneticsSociety in Montreal. Come to their booth and get a free copy! Missing my co-senior author @KeoluFox.
Andrew Farnum retweeted
Lux family co @VariantBio
we created + funded this company to find outlier people in outlier parts of the world with outlier traits...
to develop new drugs for all of the rest of us.
Out today on the cover of @ScienceMagazine: work led by @KeoluFox (UCSD) and Alexander Ioannidis (Stanford) with @VariantBio. Polynesians experienced founder effects 10x stronger than Finland’s, with big implications for drug discovery and clinical care: science.org/doi/10.1126/scie…
Andrew Farnum retweeted
Our study on Polynesian founder effects is on the cover of @ScienceMagazine! Led by @KeoluFox and @alexGioannidis with data from a @VariantBio study in French Polynesia, it finds founder effects 10x+ stronger than in Finland. Huge validation of our thesis, and much more to come!
Andrew Farnum retweeted
Out today on the cover of @ScienceMagazine: work led by @KeoluFox (UCSD) and Alexander Ioannidis (Stanford) with @VariantBio. Polynesians experienced founder effects 10x stronger than Finland’s, with big implications for drug discovery and clinical care: science.org/doi/10.1126/scie…
Andrew Farnum retweeted
Variant Bio leverages AI-powered Inference platform in an expanded collaboration with @Boehringer: medium.com/variantbio/expand…


















